Table: Kaken Pharmaceutical -Q1 group results

KAKEN PHARMACEUTICAL

03/08/2020 05:30

Aug 3 (Reuters)- 
             Kaken Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2020        Jun 30, 2019     Mar 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             18.07               22.34            82.90    
                 (-19.1 pct)         (-7.5 pct)       (-7.1 pct)  
  Operating          5.03                6.71            20.80    
                 (-25.0 pct)         (+18.7 pct)      (-21.5 pct) 
  Recurring          5.25                6.90            21.20    
                 (-23.9 pct)         (+18.6 pct)      (-21.3 pct) 
  Net                3.82                4.83            15.00    
                 (-20.8 pct)         (+19.6 pct)      (-22.6 pct) 
  EPS             98.18 yen          121.65 yen       385.94 yen  
  Ann Div                            150.00 yen       150.00 yen  
  -Q2 div                             75.00 yen        75.00 yen  
  -Q4 div                             75.00 yen        75.00 yen  
  
  NOTE - Kaken Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T